One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

T cells are white blood cells called lymphocytes essential to your immune system in the fight against infections and cancer. Ryan Teague, Ph.D., professor of molecular microbiology and immunology at ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...

Rondo Therapeutics, a private biopharmaceutical company pioneering next-generation bispecific antibody platforms, has named Thomas Manley, M.D., as Chief Medical Officer (CMO). Dr. Manley will lead ...

Catumaxomab was the first T-cell engager trifunctional antibody and the first drug in the world approved specifically for the treatment of MA and has since proven its safety and anti-tumor efficacy in ...

REDWOOD CITY, CA & BOSTON, MA, USA I 18, 2024 I Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...

The paper, published in “Cancer Cell” on Nov. 7, describes a protein that prevents ... “I am confident to say that this ...